Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2003
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199541 topical bactericides and disinfectants for surgical instruments; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen; (SML pat indexing merged to app)
10/23/2003US20030199538 Imidazoquinoline amines, imidazotetrahydroquinoline amines, imidazopyridine amines and other amines containing heterocyclic rings, a fatty acid and a hydrophobic, aprotic component miscible with fatty acid; useful for skin disorders
10/23/2003US20030199534 Kinase inhibitors
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199502 Indoloquinazolinones
10/23/2003US20030199498 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
10/23/2003US20030199491 Quinoline derivatives having vegf inhibiting activity
10/23/2003US20030199479 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003US20030199463 For therapy of cardiovascular disease, fibrotic disease
10/23/2003US20030199456 Sodium channel blockers
10/23/2003US20030199446 Stabilizers of DNA to prevent mutations caused by ultriviolet radiation and resulting in skin tumour cells; topical; anticarcinogenic and -tumor agents; sunscreen agents; stabilizers of gene p53 and protein p53
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198697 Administering plant extracts; health food
10/23/2003US20030198692 Red algae extract; human, veterinary medicine; mixture of cell permeability agent and microbiocide
10/23/2003US20030198682 Encapsulation cosmetic in water soluble polysaccharides; topical applying to human skins
10/23/2003US20030198656 N-acetylamino acids, related N-acetyl compounds and their topical use
10/23/2003US20030198646 Sealed tube containing papilla cells; induction hair growth
10/23/2003US20030198632 Thermolysin enzymatic wound debrider
10/23/2003US20030198631 Thermolysin enzymatic wound debrider
10/23/2003US20030198614 Hair growers
10/23/2003US20030198609 Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression
10/23/2003US20030198608 Ultraviolet absorbent, photostabilizer, ultraviolet ray-absorbing composition, photostabilized composition and external prepraration for skin
10/23/2003CA2484261A1 Piperidine derivatives having ccr3 antagonism
10/23/2003CA2482940A1 Hair growth tonic
10/23/2003CA2482893A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
10/23/2003CA2482713A1 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003CA2482382A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481855A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481669A1 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003CA2481478A1 Stimulation of nerve cell regeneration
10/23/2003CA2481387A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003CA2481372A1 Method to inhibit cell growth using oligonucleotides
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2481282A1 Protein a compositions and methods of use
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2481178A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003CA2480860A1 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003CA2480758A1 Tyrosine kinase inhibitors
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/23/2003CA2480332A1 Drinking tea for treating dermatitis
10/23/2003CA2480331A1 Lotion for therapy of dermatitis
10/23/2003CA2480221A1 Cream for therapy of dermatitis
10/23/2003CA2480217A1 G-type peptides to ameliorate atherosclerosis
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1354878A2 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
10/22/2003EP1354877A1 Hetero-tricyclic compounds having substituted amino groups
10/22/2003EP1354603A1 Concomitant drugs
10/22/2003EP1354595A1 Composition containing extracts of butyrospermum parkii and its use as medicament or dietary supplement
10/22/2003EP1354593A1 use of an extract of a non-photosynthetic filamentous bacterium as an agent for enhancing the endogenous synthesis of superoxide dismutase
10/22/2003EP1354591A1 Topical composition containing agglomerated particles from smoke
10/22/2003EP1354586A1 The use of hydroxpyridone-derivatives in wound healing
10/22/2003EP1354580A1 Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same
10/22/2003EP1354047A2 Methods for screening compounds that modulate lipid metabolism
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353912A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353904A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2003EP1353697A1 Method of preparing biological materials and preparation produced using same
10/22/2003EP1353687A2 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof
10/22/2003EP1353679A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/22/2003EP1353672A2 Synthesis of 3-amino-thalidomide and its enantiomers
10/22/2003EP1353645A1 Method for the production and use of a cream containing vitamin-a.
10/22/2003EP1353644A1 Use of an isothiocyanate, a thiocyanate or a mixture thereof as depigmenting agent
10/22/2003EP1047665B1 Matrix metalloprotease inhibitors
10/22/2003EP0896522B1 Methods of regulating skin appearance with vitamin b 3 compound
10/22/2003CN1451045A IFN-alpha homologues
10/22/2003CN1451043A Dual specificity antibodies and methods of making and using
10/22/2003CN1451006A I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450998A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450997A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450912A CD40 antagonists for use in treating psoriasis and other inflammatory skin conditions
10/22/2003CN1450907A Beta glycan as an inhibin receptor and uses thereof
10/22/2003CN1450890A Novel compositions of minoxidil
10/22/2003CN1450083A Citrullinylarginine dipeptide analogs and their dermatological uses as care and treatment agents
10/22/2003CN1450059A Medicinal compound with anti-infection, anti-inflammatory and antipyretic, and improving immunity function
10/22/2003CN1449804A External used germinal pharmaceutics and preparation process thereof
10/22/2003CN1449803A Oral medication germinal preparation and making process thereof
10/22/2003CN1449770A Ointment for treating burn and making process thereof
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CN1125079C Cyclopeptolides
10/22/2003CN1125070C Pyrrolo [2,3-d] pyrmidine compounds, and compositions and use thereof
10/22/2003CN1125054C Novel imidazolidine derivatives, their preparation their use and pharmaceutical preparations comprising them
10/22/2003CN1124877C Solid and semi-solid hydrocarbon gels and use thereof
10/22/2003CN1124855C Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and verterinary medical field
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635762 Monocyclic-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
1 ... 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 ... 1065